Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

2.

Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.

Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD.

J Infect Dis. 2003 Nov 1;188(9):1371-81. Epub 2003 Oct 31.

3.

Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects.

Swaminathan S, Subash PP, Rengachari R, Kaliannagounder K, Pradeep DK.

Parasit Vectors. 2008 Feb 12;1(1):2. doi: 10.1186/1756-3305-1-2.

4.

Modelling the epidemiology, transmission and control of lymphatic filariasis.

Das PK, Subramanian S.

Ann Trop Med Parasitol. 2002 Dec;96 Suppl 2:S153-64.

PMID:
12625928
5.

Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions.

Stolk WA, Stone C, de Vlas SJ.

Adv Parasitol. 2015 Mar;87:249-91. doi: 10.1016/bs.apar.2014.12.005. Epub 2015 Feb 13. Review.

PMID:
25765197
6.

EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis.

Norman RA, Chan MS, Srividya A, Pani SP, Ramaiah KD, Vanamail P, Michael E, Das PK, Bundy DA.

Epidemiol Infect. 2000 Jun;124(3):529-41.

7.

LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages.

Stolk WA, de Vlas SJ, Borsboom GJ, Habbema JD.

Parasitology. 2008 Nov;135(13):1583-98. doi: 10.1017/S0031182008000437.

PMID:
19006602
8.

The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India.

Subramanian S, Stolk WA, Ramaiah KD, Plaisier AP, Krishnamoorthy K, Van Oortmarssen GJ, Dominic Amalraj D, Habbema JD, Das PK.

Parasitology. 2004 May;128(Pt 5):467-82.

PMID:
15180315
10.
11.

Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya.

Njenga SM, Wamae CN, Njomo DW, Mwandawiro CS, Molyneux DH.

Trans R Soc Trop Med Hyg. 2008 Oct;102(10):1017-24. doi: 10.1016/j.trstmh.2008.04.039. Epub 2008 Jun 11.

PMID:
18550135
12.

Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control.

Michael E, Malecela-Lazaro MN, Kazura JW.

Adv Parasitol. 2007;65:191-237.

PMID:
18063097
13.

Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions.

Michael E, Malecela-Lazaro MN, Maegga BT, Fischer P, Kazura JW.

Trends Parasitol. 2006 Nov;22(11):529-35. Epub 2006 Sep 12.

PMID:
16971182
14.
15.

PCR and Mosquito dissection as tools to monitor filarial infection levels following mass treatment.

Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit TG.

Filaria J. 2003 Jul 7;2(1):11.

16.

Herd immunity to filarial infection is a function of vector biting rate.

Michael E, Bundy DA.

Proc Biol Sci. 1998 May 22;265(1399):855-60.

17.

Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study.

Kretzschmar M, Turner KM, Barton PM, Edmunds WJ, Low N.

Sex Transm Infect. 2009 Sep;85(5):359-66. doi: 10.1136/sti.2009.036251. Epub 2009 May 18.

PMID:
19454407
18.

Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme.

Ramaiah KD, Thiruvengadam B, Vanamail P, Subramanian S, Gunasekaran S, Nilamani N, Das PK.

Trop Med Int Health. 2009 Aug;14(8):870-6. doi: 10.1111/j.1365-3156.2009.02307.x. Epub 2009 Jun 22.

20.

Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.

Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW.

Trends Parasitol. 2006 May;22(5):226-33. Epub 2006 Mar 27. Review.

PMID:
16564745
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk